CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progre...
Gespeichert in:
Veröffentlicht in: | Neuron (Cambridge, Mass.) Mass.), 2022-11, Vol.110 (21), p.3549-3565 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3565 |
---|---|
container_issue | 21 |
container_start_page | 3549 |
container_title | Neuron (Cambridge, Mass.) |
container_volume | 110 |
creator | Franklin, Robin J.M. Simons, Mikael |
description | Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.
In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals. |
doi_str_mv | 10.1016/j.neuron.2022.09.023 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2725194263</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896627322008625</els_id><sourcerecordid>2725194263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</originalsourceid><addsrcrecordid>eNp9kEFP3DAQha0KVJal_6BCOXJJsB3HsTlUqlbdgoTooS1Xy2tPhFexndoOEv--2S7lyGmkmfdm3nwIfSa4IZjw630TYE4xNBRT2mDZYNp-QCuCZV8zIuUJWmEhec1p356h85z3GBPWSfIRnbWcUsFJu0KPm4efVQL_AqMLurgYKh1s5cIwau__NW6qbYq-2unsTOXBPOngss9ViVV5gqQnmMsyidMUU5mDKw7yBTod9Jjh02tdo9_bb782t_X9j-93m6_3tWFYlJozQ5e8PZFaDNgS2VvGOysENktWA5L1jInB7PpBmN1gum7orWgl1pZba1m7RlfHvVOKf2bIRXmXDYyjDhDnrGhPOyIZ5e0iZUepSTHnBIOakvM6vSiC1YGo2qsjUXUgqrBUC9HFdvl6Yd55sG-m_wgXwZejAJY_nx0klY2DYMC6BKYoG937F_4C_02Kig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2725194263</pqid></control><display><type>article</type><title>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Franklin, Robin J.M. ; Simons, Mikael</creator><creatorcontrib>Franklin, Robin J.M. ; Simons, Mikael</creatorcontrib><description>Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.
In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2022.09.023</identifier><identifier>PMID: 36228613</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Humans ; Inflammation ; Multiple Sclerosis - therapy ; Myelin Sheath - physiology ; Oligodendroglia - physiology ; Remyelination</subject><ispartof>Neuron (Cambridge, Mass.), 2022-11, Vol.110 (21), p.3549-3565</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</citedby><cites>FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</cites><orcidid>0000-0001-6522-2104</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0896627322008625$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36228613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Franklin, Robin J.M.</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><title>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</title><title>Neuron (Cambridge, Mass.)</title><addtitle>Neuron</addtitle><description>Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.
In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.</description><subject>Humans</subject><subject>Inflammation</subject><subject>Multiple Sclerosis - therapy</subject><subject>Myelin Sheath - physiology</subject><subject>Oligodendroglia - physiology</subject><subject>Remyelination</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFP3DAQha0KVJal_6BCOXJJsB3HsTlUqlbdgoTooS1Xy2tPhFexndoOEv--2S7lyGmkmfdm3nwIfSa4IZjw630TYE4xNBRT2mDZYNp-QCuCZV8zIuUJWmEhec1p356h85z3GBPWSfIRnbWcUsFJu0KPm4efVQL_AqMLurgYKh1s5cIwau__NW6qbYq-2unsTOXBPOngss9ViVV5gqQnmMsyidMUU5mDKw7yBTod9Jjh02tdo9_bb782t_X9j-93m6_3tWFYlJozQ5e8PZFaDNgS2VvGOysENktWA5L1jInB7PpBmN1gum7orWgl1pZba1m7RlfHvVOKf2bIRXmXDYyjDhDnrGhPOyIZ5e0iZUepSTHnBIOakvM6vSiC1YGo2qsjUXUgqrBUC9HFdvl6Yd55sG-m_wgXwZejAJY_nx0klY2DYMC6BKYoG937F_4C_02Kig</recordid><startdate>20221102</startdate><enddate>20221102</enddate><creator>Franklin, Robin J.M.</creator><creator>Simons, Mikael</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6522-2104</orcidid></search><sort><creationdate>20221102</creationdate><title>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</title><author>Franklin, Robin J.M. ; Simons, Mikael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Humans</topic><topic>Inflammation</topic><topic>Multiple Sclerosis - therapy</topic><topic>Myelin Sheath - physiology</topic><topic>Oligodendroglia - physiology</topic><topic>Remyelination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franklin, Robin J.M.</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franklin, Robin J.M.</au><au>Simons, Mikael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><addtitle>Neuron</addtitle><date>2022-11-02</date><risdate>2022</risdate><volume>110</volume><issue>21</issue><spage>3549</spage><epage>3565</epage><pages>3549-3565</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.
In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36228613</pmid><doi>10.1016/j.neuron.2022.09.023</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-6522-2104</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0896-6273 |
ispartof | Neuron (Cambridge, Mass.), 2022-11, Vol.110 (21), p.3549-3565 |
issn | 0896-6273 1097-4199 |
language | eng |
recordid | cdi_proquest_miscellaneous_2725194263 |
source | MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Humans Inflammation Multiple Sclerosis - therapy Myelin Sheath - physiology Oligodendroglia - physiology Remyelination |
title | CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A06%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CNS%20remyelination%20and%20inflammation:%20From%20basic%20mechanisms%20to%20therapeutic%20opportunities&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Franklin,%20Robin%20J.M.&rft.date=2022-11-02&rft.volume=110&rft.issue=21&rft.spage=3549&rft.epage=3565&rft.pages=3549-3565&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2022.09.023&rft_dat=%3Cproquest_cross%3E2725194263%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2725194263&rft_id=info:pmid/36228613&rft_els_id=S0896627322008625&rfr_iscdi=true |